MARCIE KAZDAN: Open Payments
NPI 1467905232 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,447 in 102 payments from 25 companies in 2025. Trend: 2023 $221 · 2024 $479 · 2025 $2,447
Food & beverage: $2,447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $354 |
| UCB, Inc. | 12 | $317 |
| Neurelis, Inc. | 8 | $193 |
| Lilly USA, LLC | 9 | $173 |
| Amneal Pharmaceuticals LLC | 3 | $142 |
| Biogen, Inc. | 6 | $134 |
| Teva Pharmaceuticals USA, Inc. | 7 | $132 |
| Alexion Pharmaceuticals, Inc. | 4 | $100 |
| EMD Serono, Inc. | 4 | $98 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
Products named: QULIPTA, Zilbrysq, VALTOCO, CREXONT, KISUNLA, AUSTEDO XR, Leqembi, ULTOMIRIS.
Industry payments across FL — which companies pay providers there.
